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Abstract
Background
Obesity and major depressive disorder (MDD)/anxiety disorders often co-occur and aggra-
vate each other resulting in adverse health-related outcomes. As little is known about the
potential effects of interaction between obesity and MDD and/or anxiety disorders on
health-related quality of life (HR-QoL), this study was aimed at examining these combined
effects.
Methods
We collected data among N = 89,332 participants from the LifeLines cohort study. We cate-
gorized body weight using body mass index (kg/m2) as normal weight (18.5–24.99), over-
weight (25–29.9), mild obesity (30–34.9) and moderate/severe obesity ( 35); we
measured abdominal obesity using a waist circumference of102 and 88 cm for males
and females, respectively. MDD and anxiety disorders were diagnosed with the Mini-Inter-
national Neuropsychiatric Interview. HR-QoL was assessed using the RAND-36 question-
naire to compute physical and mental quality of life scores. We used binary logistic and
linear regression analyses.
Results
The combined effect of obesity and MDD and/or anxiety disorders on physical QoL was
larger than the sum of their separate effects; regression coefficients, B (95%-confidence
interval, 95%-CI) were: - 1.32 (-1.75; -0.90). However, the combined effect of obesity and
major depression alone on mental QoL was less than the additive effect. With increasing
body weight participants report poorer physical QoL; when they also have MDD and/or
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anxiety disorders participants report even poorer physical QoL. In persons without MDD
and/or anxiety disorders, obesity was associated with a better mental QoL.
Conclusions
Obesity and MDD and/or anxiety disorders act synergistically on physical and mental QoL.
The management of MDD and/or anxiety disorders and weight loss may be important routes
to improve HR-QoL.
Introduction
Obesity, major depressive disorder (MDD) and anxiety disorders are major public health prob-
lems, posing enormous challenges for the decades to come [1,2]. Obesity and MDD and/or
anxiety disorders are associated with long-term disability, morbidity and mortality, and enor-
mous economic costs [3–5]. Since the 1980s the prevalence of obesity has tripled in many
countries of the World Health Organization (WHO) European Region, and continues to rise at
an alarming rate. The rate of MDD and/or anxiety disorders has also increased in the past
decade. For instance, in the UK, the incidence of depressive symptoms rose threefold from the
baseline of 5.11/1000 person years in 1996 to 15.5/1000 person years in 2006 [4,6]. MDD is
even expected to be one of the top leading causes of disability-adjusted life years in 2030 [7].
Obesity and MDD and/or anxiety have become the most serious health risks today, and are
associated with major chronic diseases such as cardiovascular diseases, type 2 diabetes, ortho-
pedic problems and certain kinds of cancer [8,9].
Co-occurrence of chronic physical conditions with MDD and/or anxiety disorders may
have even worse consequences, including a poorer health-related quality of life (HR-QoL) [10].
HR-QoL has gained increasing interest as an outcome measure in clinical practice and public
health settings [11]. Alley et al showed that obesity is associated with poor QoL, especially due
to its earlier age of onset and long-term exposure [12]. MDD and/or anxiety disorders are also
associated with significant reductions in HR-QoL [4]. During a depressive episode, a patient’s
level of HR-QoL is the same as that of as a patient with a severe stroke [13].
Several studies have reported that obesity and MDD and/or anxiety disorders often co-
occur and are bidirectionally inter-related [14–16]. However, obesity and MDD and/or anxiety
disorders have more often been considered separate conditions without taking into account
their potential interaction on HR-QoL. For example, the effect of general and abdominal obe-
sity on HR-QoL may further increase in persons with MDD and/or anxiety disorders com-
pared to those without such disorders. Regarding this, the general obesity reflects excess total
body fat whereas abdominal obesity in particular reflects excess visceral fat which has been sug-
gested to be in particular deleterious [17]. However, for both obesity and abdominal obesity lit-
tle is known about the potential effects of their interaction with MDD and/or anxiety disorders
on HR-QoL. The main reasons to examine their interaction or combined effect on HR-QoL
are: 1) obesity and MDD are bidirectionally related and overlapping risk factors for major
chronic diseases [14–16,18]; 2) patients with obesity and MDD share pleiotropic genes (12–
20%) and have many common features that make them valuable to examine as a distinct popu-
lation of interest [14–16,19,20]; and 3) both obesity and MDD and/or anxiety disorders lead to
an enormous individual and global burden of disease and disability [1,2]. Therefore, obesity
and MDD and/or anxiety disorders may interact thereby augmenting one another’s effect on
HR-QoL, and substantially reducing the HR-QoL in people with both exposures.
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The interaction between obesity and MDD and/or anxiety disorders on HR-QoL can best
be measured by statistical interaction on the additive scale as opposed to conventional interac-
tion [21]. On the one hand, knowledge on interaction effects on the additive scale could pro-
vide empirical evidence for public health interventions in vulnerable groups; on the other
hand, knowledge on interactions on the multiplicative scale is more relevant in disease etiology
[22]. The present study focuses essentially on interaction on the additive scale (i.e. comparing
the sum of separate effects of obesity and MDD and/or anxiety versus the combined effect). It
is very important to be aware of a slight arbitrariness of interaction on the additive scale from
the conventional interaction in terms of defining, detecting and interpreting the interaction
effect, particularly for continuous outcomes. In conventional interaction, for instance, it is
assumed in advance that obesity modifies the effect of MDD and/or anxiety on poor HR-QoL
(i.e. unidirectional). In contrast, the interaction on the additive scale concept considers the
potential bidirectional interaction effect of obesity and MDD and/or anxiety on poor HR-QoL,
because obesity and MDD and/or anxiety do not precede each other. For instance, if the com-
bined effect of obesity and MDD and/or anxiety disorders surpasses the sum of their separate
effects, then intervening on obesity might also reduce the effect of MDD and/or anxiety disor-
ders on poor HR-QoL and vice versa.
Therefore, the aim of this study was to examine the combined effect of obesity and MDD
and/or anxiety disorders on HR-QoL and to determine whether the effect of obesity on
HR-QoL further increases in persons with and without MDD and/or anxiety disorders. Inter-
action on the additive scale was used as a measure to test the hypothesis that the combined
effect of obesity and MDD and/or anxiety disorders on HR-QoL was larger than the sum of the
separate effects.
Material and Methods
Study design and population
Data were collected in the ongoing LifeLines Cohort Study, a multi-disciplinary prospective
population-based cohort study examining in a unique three-generation design the health and
health-related behaviors of 167,729 persons living in the north of The Netherlands. The study
employs a broad range of investigative procedures to assess the biomedical, socio-demographic,
behavioral, physical and psychological factors which contribute to the health and disease of the
general population, with a special focus on multi-morbidity and complex genetics. The design
of the LifeLines cohort study has been described elsewhere [23]. For the study, we included
N = 89,332 persons, who were enrolled between November 2006 and June 2013. Inclusion cri-
teria for the present study were: age 18 years and older, psychiatric diagnosis, anthropometric
measurements, and complete data on HR-QoL.
The LifeLines study protocol was approved by the Ethical Review Board of the University
Medical Center Groningen. After receiving full verbal and written information about the study,
all participants gave written informed consent. The study was conducted in accordance with
the Declaration of Helsinki.
Measurements
General and abdominal obesity. General obesity was assessed using the body mass index
(BMI). The BMI was calculated from measured body weight (kg) and height (m). Participants
were classified into four BMI classes according to the standard international classification of
the World Health Organization (WHO): normal weight (BMI: 18.5–24.99 kg/m2), overweight
(BMI 25.0–29.99 kg/m2), mild obesity (BMI 30.0–34.99 kg/m2) and moderate/severe obesity
(BMI 35.0 kg/m2). Abdominal obesity was defined using objectively measured waist
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circumference (WC) of102 cm and88 cm for males and females, respectively [24]. We
included abdominal obesity because BMI has been criticized for its inadequate reflection of
body composition and we wanted to make our analyses robust. Anthropometric measurements
were conducted by nurses during a visit at the LifeLines test location.
Major depressive disorders (MDD) and anxiety disorders. MDD and anxiety disorders
(generalized anxiety disorder (GAD), social phobia, panic and agoraphobia) were assessed by
using the Mini-International Neuropsychiatric Interview (MINI) [25]. The MINI is a short
structured diagnostic interview. It is compatible with international diagnostic criteria, includ-
ing the International Classification of Diseases (ICD-10) and the fourth edition of the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-IV) [25]. The MINI was designed to meet
the need for a short (15 minutes) but accurate structured psychiatric interview for epidemio-
logical studies. The MINI has an excellent inter-rater reliability (Kappa, k> 90), and high
retest reliability (k = 0.87 for MDD, k = 0.78 for anxiety disorders) [25]. The MINI interview
was conducted by trained interviewers.
Health-related quality of Life (HR-QoL). HR-QoL was assessed by the RAND-36 ques-
tionnaire. The RAND-36 is a generic and widely used measure of HR-QoL, designed for use in
clinical practice and research, health policy evaluations, and general population surveys [19]. It
has been adapted for use in various countries, including the Netherlands [26,27]. The question-
naire covers eight dimensions: Physical Functioning, Role Limitations due to Physical Func-
tioning (Role-Physical), Bodily Pain, General Health, Vitality, Social Functioning, Role
Limitations due to Emotional Functioning (Role-Emotional), and Mental Health. Two sum-
mary scores of QoL can be calculated: the physical component summary (PCS) and the mental
component summary (MCS) scores, reflecting physical and mental QoL, respectively. These
summary scores provide information on the patient’s physical and mental QoL in just two val-
ues, thereby reducing the number of statistical analyses needed and offering easier interpreta-
tion of the data [28]. The PCS- and MCS-scores have good discriminant validity for identifying
differences between clinically meaningful groups [29]. The eight domains and two summary
scores range from 0 to 100, with higher scores indicating better HR-QoL. PCS- and MCS-
scores were computed by using recommended scoring algorithms[30], and standardized by
linear z-score transformation to have a mean of 50 and standard deviations of 10 in the US gen-
eral population.
Covariates. Covariates concerned sociodemographic characteristics (age, sex and educa-
tional status), lifestyle factors (smoking, alcohol consumption and physical exercise) and com-
mon chronic conditions (cardiovascular diseases, hypertension, diabetes, rheumatoid arthritis
and cancer). Age was measured in years. Educational level was categorized into low (primary
and lower secondary education), middle (higher secondary education) and high education (ter-
tiary or higher education). Physical exercise was defined as the frequency per week in which
the respondent typically engaged in moderate physical activities (e.g. walking, bicycling, gar-
dening and household work) for at least half an hour, it was then categorized into high (twice
or more per week), medium (once per week) and low (do not exercise/ hardly per week). Smok-
ing status was dichotomized into current smokers and non-smokers. Alcohol intake was
assessed based on intake frequency and the average number of units consumed on a drinking
day. The number of alcoholic drinks per week was determined by multiplying the number of
drinking days per week by the average number of units consumed on a drinking day. The num-
ber of alcoholic drinks/week was then divided by 7 to obtain the average number of alcoholic
drinks per day. High alcohol consumption was defined as drinking more than an average of 2
drinks of alcohol per day [31]. Common chronic illnesses were assessed by taking the current
and/or past history of chronic physical conditions (i.e. cardiovascular diseases, hypertension,
diabetes, rheumatoid arthritis and cancer) [26,32].
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Statistical analyses
First, we described participants’ sociodemographics, lifestyle factors, psychopathology and
chronic conditions as frequencies, means and standard deviations, using the four BMI catego-
ries and abdominal obesity status. The associations of BMI categories and abdominal obesity
with MDD and/or anxiety disorders were assessed using binary logistic regression.
Second, we assessed the average deviation in HR-QoL scores for overweight, obese (mild to
moderate or severe) persons compared to normal weight persons by MDD and/or anxiety dis-
orders status using one-way analysis of variance (ANOVA). Third, we examined the combined
effect of obesity and MDD and/or anxiety disorders on physical and mental QoL. We assessed
the presence of interactions by testing the significance of the increment in squared multiple
correlation (ΔR2) by including the product terms (overweight/obesity x MDD and/or anxiety
disorders) in the model adjusted for obesity and MDD and/or anxiety disorders, and also by
testing whether the coefficient for the product terms differs from 0 [33]. The regression coeffi-
cient of the product term (β) reflects interaction as departure from additivity and is the abso-
lute value difference between the combined effect and the separate effects of obesity and MDD
and/or anxiety disorders on physical and mental QoL [21]. The combined effect of obesity and
MDD and/or anxiety disorders on physical or mental QoL as measured on a continuous scale
is given by the sum of the separate effects of obesity, MDD and/or anxiety disorders and the
product term. A synergistic effect of obesity and MD/anxiety on physical and mental QoL is
reflected as B< 0, while B> 0 represents a negative interaction (antagonistic) of obesity and
MDD and/or anxiety disorders on physical and mental QoL:B = 0 represents no interaction
effect of obesity and MDD and/or anxiety disorders on physical and mental QoL.
Fourth, using linear regression models, we examined the association of BMI categories with
physical and mental QoL in persons with and without MDD and/or anxiety disorders. In these
analyses, we tested four different models of general and abdominal obesity to adjust for other
variables potentially affecting the associations of obesity and/or MDD and/or anxiety disorders
with physical and mental QoL. Model 1 tested the crude association of overweight and obesity
categories with physical and mental QoL compared to normal weight category, and stratified
by MDD and/or anxiety disorders status. Model 2 adjusted additionally for socio-demographic
factors (i.e. age, sex and education). In Model 3, lifestyle factors (i.e. physical exercise, smoking
and alcohol) were added, and Model 4 contained all variables fromModel 3 plus major chronic
conditions (i.e. cardiovascular diseases, hypertension, diabetes, rheumatoid arthritis and
cancer).
All analyses were performed using SPSS statistical software (SPSS version 22.0), a two-sided
p<0.05 was considered statistically significant.
Results
Sample characteristics
Table 1 shows the characteristics of participants (N = 89,332) by BMI categories and abdomi-
nal obesity status. The prevalences of overweight, mild obesity, moderate/severe obesity and
abdominal obesity were 40%, 12%, 4% and 36%, respectively, and of MDD and/or anxiety dis-
orders was 11%. In addition, mild, moderate/severe and abdominal obesity were associated
with MDD and/or anxiety disorders (odds ratio, OR (95% confidence interval, CI): = 1.20
(1.12; 1.28), 1.81 (1.65; 1.99) and 1.40 (1.34; 1.46)), respectively. Overweight was not associated
with MDD/anxiety disorders OR = 0.96 (0.91; 1.01).
In Table 2 we present the average deviation in HR-QoL domains in participants with obesity
and MDD and/or anxiety disorders compared with normal weight counterparts. On all
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physical health measures and health perceptions overweight and obese persons had a signifi-
cantly poorer HR-QoL than normal weight persons (Table 2). However, overweight and nor-
mal weight participants showed no difference in psychosocial aspects of HR-QoL (social
functioning and emotional role) (p<0.01).
The combined effect of obesity and MDD and/or anxiety disorders on
HR-QoL
Table 3 shows the interaction of obesity and major depression/anxiety with physical and men-
tal quality of life, which is the main finding of this study. We found that the combined effect of
obesity and MDD and anxiety on physical QoL was (B = -1.32, 95%CI: -1.75; -0.90 and B =
-1.27, 95%CI: -1.73; -0.81, respectively (Table 3). The interaction effect sizes of B = -1.32
Table 1. LifeLines cohort characteristics by BMI categories and abdominal obesity.
BMI categories Abdominal
Characteristics Total
N = 89,332
Normal weight
n = 39960 (44.7%)
Over-weight
n = 35355 (39.6%)
Mild obesity
n = 10551 (11.8%)
Moderate/ severe
obesity n = 3466
(3.9%)
obesitya
n = 32231
(36.1%)
Age, mean (SD) 44.4(12.3) 41.8 (12.3) 46.5 (12.0) 47.0 (11.7) 45.3 (11.0) 47.6 (11.8)
Sex, females, (%) 58.6 65.5 49.3 57.9 75.2 70.7
Educational status, (%)
High 29.7 35.7 27.1 20.2 16.0 22.1
Middle 40.2 40.6 39.6 39.7 41.8 39.3
Low 30.1 23.7 33.4 40.1 42.2 38.6
Frequency of exercise,
(%)
High ( 2x/wk) 86.8 87.9 87.0 84.0 79.5 84.6
Medium (1x/wk) 8.6 8.0 8.7 10.0 11.5 9.7
Low (No or hardly/
wk)
4.6 4.1 4.3 6.0 9.0 5.7
Current smokers, (%) 21.5 22.5 21.1 19.8 18.6 20.3
High alcohol
consumption, (%)
8.0 6.8 9.5 8.7 5.3 7.5
Major depression, (%) 2.2 2.0 1.9 3.1 5.7 3.0
Anxiety disorders, (%) 9.9 9.6 9.3 11.1 15.5 11.8
Common chronic
conditions
Hypertension, (%) 25.3 15.9 28.1 41.8 51.7 37.1
Cardiovascular
diseases, (%)
3.3 2.4 3.6 4.6 6.1 4.6
Diabetes, (%) 2.3 0.8 2.3 5.4 9.1 4.4
Rheumatoid arthritis,
(%)
3.2 2.4 3.2 5.0 8.5 5.2
Cancer, (%) 4.4 4.0 4.7 4.6 4.5 5.4
HR-QoL (PCS, MCS)
PCS, mean (SD) 51.3 (7.2) 52.3 (6.6) 51.2 (7.1) 49.2 (8.3) 46.8 (9.4) 49.6 (8.1)
MCS, mean (SD) 52.6 (8.4) 52.2 (8.4) 53.1 (8.1) 52.7 (8.8) 51.8 (9.8) 52.3 (7.2)
HR-QoL: Health-related quality of life; PCS: physical component summary score; MCS: mental component summary score; Normal weight (BMI: 18.5–
24.99 kg/m2), overweight (BMI 25.0–29.99 kg/m2), mild obesity (BMI 30.0–34.99 kg/m2) and moderate/severe obesity (BMI  35.0 kg/m2)
a Waist circumference (WC)  102 cm for males and 88cm for females.
doi:10.1371/journal.pone.0148871.t001
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indicated that the combined effect of obesity and MDD and/or anxiety disorders on physical
QoL was greater than the additive effect. However, the combined effect of obesity and major
depression alone on mental QoL was less than the additive effect (Table 3).
Furthermore, our stratified analysis revealed a significant association of physical QoL across
BMI categories and abdominal obesity in depressed and anxious individuals (Table 4). How-
ever, the association of obesity and mental QoL was not statistically significant in depressed
and anxious individuals in the general population. In non-depressed and anxious individuals,
obesity was significantly associated with better mental QoL (Table 5).
Discussion
In this large, representative cohort study, we found that the combined effects of obesity and
MDD and/or anxiety disorders on physical and mental QoL were greater than the sum of their
separate effects. Moreover, general and abdominal obesity were significantly associated with a
poorer physical QoL in persons with and without MDD and/or anxiety disorders after adjust-
ment for potential confounders. General and abdominal obesity were found to be associated
with better mental QoL in persons without MDD/anxiety disorders. This association was not
found in persons with MDD/anxiety disorders after adjustment for potential confounders.
The combined effect of obesity and MDD and/or anxiety disorders on physical QoL was sig-
nificantly larger than the sum of their estimated separate effects. As indicated in the interaction
model, the average physical QoL for obese persons (BMI30) with MDD was 4.46 points
lower than that of non-obese non-depressed persons. With sufficient-cause interaction in
mind, obesity and MDD and/or anxiety disorders are component causes that act in concert
and are associated with poor physical QoL. Obesity may interact with MDD and/or anxiety dis-
orders, whereby each augmenting the effect of the other on physical QoL. Although this finding
is based on cross-sectional data, it seems plausible because obesity shares genetic and complex
biologic etiologic substrates with MDD and/or anxiety disorders [14,20,34]. Although the pres-
ence of inflammatory responses and the crucial role of cytokines have been established more
Table 3. The separate association of obesity, major depression/anxiety and their interactions with physical andmental quality of life.
Parameter Physical QoL (PCS-score) Mental QoL (MCS-score)
Crude estimate Adjusted estimate Crude estimate Adjusted
B(95%-CI) B(95%-CI)a B(95%-CI) B(95%-CI)a
Obesity -2.96 (-3.09; -2.83) -2.25 (-2.41; -2.10) 0.20 (0.05; 0.34) 0.29 (0.12; 0.45)
Major depression alone -1.50 (-1.68; -1.32) -1.10 (-1.33; -0.88) -10.10 (-10.31; -9.90) -9.85 (-10.09; -9.60)
Obesity x Major depression -1.28 (-1.65; -0.92) -1.32 (-1.75; -0.90) 0.57 (0.18, 0.97) 0.59 (0.13; 1.05)
Obesity -2.89 (-3.03; -2.76) -2.20 (-2.36; -2.04) 0.23 (0.08; 0.38) 0.29 (0.12; 0.46)
Anxiety alone -1.50 (-1.67; -1.32) -1.23 (-1.43; -1.03) -10.61 (-10.80; -10.42) -9.81 (-10.03; -9.59)
Obesity x anxiety -1.43 (-1.83; -1.03) -1.27 (-1.73; -0.81) -0.50 (-0.93; -0.07) -0.60 (-1.09; -0.10)
Obesity -2.84 (-2.98; -2.70) -2.17 (-2.33; 2.01) 0.34 (0.20; 0.50) 0.37 (0.20; 0.54)
Major depression/anxiety -0.80 (-0.89; -0.72) -0.64 (-0.74; -0.54) -5.52 (-5.61; -5.43) -5.12 (-5.23; -5.02)
Obesity x Major depression/anxiety -0.82 (-1.01; -0.62) -0.70 (-0.92; -0.48) -0.35 (-0.56; -0.15) -0.40 (-0.63; -0.16)
Abbreviations: PCS: physical component summary score; MCS: Mental component summary score; Obesity (BMI  30.0 kg/m2) compared to non-obese.
a Adjusted for age, sex, educational status, smoking, exercise, alcohol consumption and major chronic conditions (i.e. cardiovascular diseases,
hypertension, diabetes, rheumatoid arthritis and cancer). For instance, the combined effect of obesity and major depression on PCS-score was = -2.96–
1.50–1.28 = -5.74, while the sum of individual effects of obesity and major depression/anxiety assuming no interaction was = -2.96–1.50 = -4.46. The
departure from additivity is given by = -5.74- (-4.46) = -1.28, by deﬁnition, the regression coefﬁcient of the product term.
doi:10.1371/journal.pone.0148871.t003
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for depression than for anxiety [35], the joint presence of MDD/anxiety disorders and obesity
can contribute to morbidity and poorer physical conditions [14,20,36]. In addition, subtypes of
both obesity and MDD and/or anxiety disorders are assumed to be related to stress, which is
characterized by endogenous overproduction of adrenocorticotrophin (ACTH) and cortisol
[37] This chronic hypercortisolism induces (abdominal) obesity and depressive symptoms,
and severely reduced HR-QoL, conditions which are all known to improve in the majority of
patients after treating the disease by surgery or medication [37]. Hence, the current study
shows that joint exposure of obesity and MDD and/or anxiety disorders decreases physical
Table 4. Crude and adjusted regression coefficients (B) for physical quality of life with general and abdominal obesity categories, stratified by
major depression/anxiety.
Mental disorder and body weight N (%) Physical component summary score of HR-QoL
Model 1 Model 2 Model 3 Model 4
B (95%-CI) B (95%-CI) B (95%-CI) B (95%-CI)
No major depression/anxiety (n = 79,820)
Normal weight 35854 (44.9) Reference Reference Reference Reference
Overweight 31833 (39.9) -1.07 (-1.19; -0.95) -0.74 (-0.86; -0.61) -0.73 (-0.85; -0.60) -0.64 (-0.76; -0.52)
Mild obesity 9266 (11.6) -2.87 (-3.05; -2.69) -2.37 (-2.55; -2.19) -2.34 (-2.52; -2.16) -1.87 (-2.05; -1.70)
Moderate/severe obesity 2867 (3.6) -5.05 (-5.35; -4.75) -4.49 (-4.79; -4.19) -4.44 (-4.73; -4.14) -3.55 (-3.84; -3.26)
No abdominal obesity 51708 (64.8) Reference Reference Reference Reference
Abdominal obesity 28112 (35.0) -2.36 (-2.48; -2.25) -1.75 (-1.87; -1.64) -1.72 (-1.84; -1.60) -1.37 (-1.49; -1.26)
Anxiety alone (n = 8838)
Normal weight 3832 (43.4) Reference Reference Reference Reference
Overweight 3298 (37.3) -1.90 (-1.94; -0.94) -1.44 (-1.94; -0.94) -1.44 (-1.94; -0.94) -1.29 (-1.79, -0.78)
Mild obesity 1172 (13.3) -4.37 (-4.34; -2.95) -3.65 (-4.34; -2.95) -3.65 (-4.35; -2.95) -3.20 (-3.90; -2.49)
Moderate/severe obesity 536 (6.1) -6.68 (-6.97; -5.07) -6.03 (-6.97; -5.07) -5.94 (-6.89; -4.99) -5.30 (-6.27; -4.33)
No abdominal obesity 5047 (57.1) Reference Reference Reference Reference
Abdominal obesity 3791 (42.9) -3.32 (-3.77; -2.87) -2.59 (-3.06; -2.13) -2.57 (-3.03; -2.11) -2.19 (-2.66; -1.72)
Major depression alone (n = 2004)
Normal weight 808 (40.3) Reference Reference Reference Reference
Overweight 673 (33.6) -2.21 (-3.54; -0.88) -1.61 (-2.95; -0.27) -1.64 (-2.98; -0.30) -1.50 (2.84; -0.15)
Mild obesity 326 (16.3) -5.69 (-7.34; -4.05) -4.92 (-6.57; -3.27) -4.89 (-6.54; -3.23) -4.60 (-6.29; -2.91)
Moderate/severe obesity 197 (9.8) -8.07 (-10.01; -6.13) -7.47 (-9.40; -5.53) -7.36 (-9.29; -5.42) -6.88 (-8.88; -4.89)
No abdominal obesity 1050 (52.4) Reference Reference Reference Reference
Abdominal obesity 954 (47.6) -4.31 (-5.45; -3.16) -3.75 (-4.92; -2.58) -3.74 (-4.91; -2.56) -3.33 (-4.54; -2.12)
Major depression/anxiety (n = 9,512)
Normal weight 4106 (43.2) Reference Reference Reference Reference
Overweight 3522 (37.0) -1.87 (-2.36; -1.38) -1.40 (-1.89; -0.90) -1.40 (-1.89; -0.91) -1.24 (-1.74; -0.75)
Mild obesity 1285 (13.5) -4.35 (-5.02; -3.67) -3.64 (-4.32; -2.97) -3.62 (-4.30; -2.95) -3.15 (-3.84; -2.47)
Moderate/severe obesity 599 (6.3) -6.97(-7.89; -6.05) -6.30 (-7.21; -5.39) -6.20 (-7.11; -5.28) -5.53 (-6.46; -4.60)
No abdominal obesity 5393 (56.7) Reference Reference Reference Reference
Abdominal obesity 4119 (43.3) -3.39 (-3.84; -2.23) -2.68 (-3.13; -2.23) -2.64 (-3.09; -2.19) -1.99 (-2.43; -1.56)
Abbreviations: HR-QoL: Health related quality of life; Normal weight (BMI: 18.5–24.99 kg/m2), overweight (BMI 25.0–29.99 kg/m2), mild obesity (BMI
30.0–34.99 kg/m2) and moderate/severe obesity (BMI  35.0 kg/m2); B; regression coefﬁcient; 95%-CI: 95%-conﬁdence interval; Model 1: Crude
estimate; Model 2: Model 1 plus sociodemographic factors (i.e. Age, sex, educational status); Model 3: Model 2 plus lifestyle factors (i.e. smoking,
exercise, alcohol consumption); Model 4: Model 3 plus major chronic conditions (i.e. cardiovascular diseases, hypertension, diabetes, rheumatoid arthritis
and cancer); Bold ﬁgures reﬂect statistically signiﬁcant estimates (p<0.05).
doi:10.1371/journal.pone.0148871.t004
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QoL, and the joint association of obesity and MDD and/or anxiety disorders is greater than the
additive effect.
The combined effect of obesity and MDD/anxiety disorders on mental QoL was also signifi-
cantly greater than the sum of their separate effects. The interaction model indicates that mean
mental QoL scores were 5.52 points lower in obese persons (BMI30) with MDD/anxiety dis-
orders than in those without such disorders. This underlines the findings of Atlantis et al [38],
who reported mean mental QoL scores of 39% to 43% points lower in all BMI groups with
MDD compared to groups with normal weight and without MDD. Although the excess
Table 5. Crude and adjusted regression coefficients (B) for mental quality of life with general and abdominal obesity categories stratified by major
depression/anxiety.
Mental disorder and body weight Mental component summary score (MCS) of HR-QoL
N (%) Model 1 Model 2 Model 3 Model 4
B (95%-CI) B (95%-CI) B (95%-CI) B (95%-CI)
No major depression/anxiety (n = 79,820)
Normal weight 35854 (44.9) Reference Reference Reference Reference
Overweight 31833 (39.9) 0.67 (0.55; 0.79) 0.11 (-0.01; 0.23) 0.12 (-0.01; 0.24) 0.19 (0.07; 0.31)
Mild obesity 9266 (11.6) 0.66 (0.48; 0.84) 0.19 (0.01; 0.37) 0.20 (0.01; 0.38) 0.38 (0.20; 0.56)
Moderate/severe obesity 2867 (3.6) 0.58 (0.29; 0.88) 0.49 (0.20; 0.80) 0.48 (0.18; 0.77) 0.77 (0.47; 1.06)
No abdominal obesity 51708 (64.8) Reference Reference Reference Reference
Abdominal obesity 28112 (35.0) 0.22 (0.11; 0.34) 0.19 (0.07; 0.31) 0.20 (0.08; 0.32) 0.34 (0.22; 0.45)
Anxiety alone (n = 8838)
Normal weight 3832 (43.4) Reference Reference Reference Reference
Overweight 3298 (37.3) 4.05 (-6.10; 12.17) 3.04 (-6.10; 12.17) 5.59 (-3.08; 14.27) 2.75 (-6.74; 12.25)
Mild obesity 1172 (13.3) 2.84 (-7.91; 13.58) 0.91 (-10.38; 12.20) 8.10 (-3.14; 19.35) 4.90 (-7.18; 16.99)
Moderate/severe obesity 536 (6.1) -18.73 (-34.58; -2.88) -20.02 (-36.19; -3.85) -10.90 (-26.95; 5.15) -16.89 (-36.07; 2.30)
No abdominal obesity 5047 (57.1) Reference Reference Reference Reference
Abdominal obesity 3791 (42.9) 0.71 (0.10; 1.31) -0.10 (-0.71; 0.53) -0.14 (-0.76; 0.48) 0.18 (-0.45; 0.82)
Major depression alone (n = 2004)
Normal weight 808 (40.3) Reference Reference Reference Reference
Overweight 673 (33.6) -3.08 (-20.87; 14.72) -5.68 (-26.72; 15.37) - -
Mild obesity 326 (16.3) 17.67 (-2.51; 37.85) 12.89 (-8.15; 33.94) - -
Moderate/severe obesity 197 (9.8) -14.09 (-34.27; 6.09) -10.45 (-29.52; 8.62) - -
No abdominal obesity 1050 (52.4) Reference Reference Reference Reference
Abdominal obesity 954 (47.6) 1.51 (0.27; 2.76) 0.88 (-0.41; 2.16) 0.86 (-0.43; 2.15) 0.95 (-0.38; 2.28)
Major depression/anxiety (n = 9,512)
Normal weight 4106 (43.2) Reference Reference Reference Reference
Overweight 3522 (37.0) 1.34 (0.69; 2.00) 0.89 (0.23; 1.55) 0.83 (0.17; 1.49) 0.98 (0.32; 1.64)
Mild obesity 1285 (13.5) 0.95 (0.05; 1.85) 0.45 (-0.3446; 1.35) 0.31 (-0.60; 1.21) 0.71 (-0.21; 1.63)
Moderate/severe obesity 599 (6.3) -1.56 (-2.79; -0.59) -1.82 (-3.04;-0.59) -1.90 (-3.12; -0.68) -1.33 (-2.58; -0.09)
No abdominal obesity 5393 (56.7) Reference Reference Reference Reference
Abdominal obesity 4119 (43.3) 0.63 (0.05; 1.22) -0.06 (-0.66; 0.54) -0.11 (-0.71; 0.49) 0.23 (-0.39; 0.84)
Abbreviations: HR-QoL: Health related quality of life; Normal weight (BMI: 18.5–24.99kg/m2), overweight (BMI 25.0–29.99 kg/m2), mild obesity (BMI 30.0–
34.99 kg/m2) and moderate/severe obesity (BMI  35.0 kg/m2); B; regression coefﬁcient;95%-CI: 95%-conﬁdence interval; Model 1: Crude estimate;
Model 2: Model 1 plus sociodemographic factors (i.e. Age, sex, educational status); Model 3: Model 2 plus lifestyle factors (i.e. smoking, exercise, alcohol
consumption); Model 4: Model 3 plus major chronic conditions (i.e. cardiovascular diseases, hypertension, diabetes, rheumatoid arthritis and cancer);
Bold ﬁgures reﬂect Statistically signiﬁcant estimates (p<0.05).
doi:10.1371/journal.pone.0148871.t005
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reduction of the mental QoL score is expected to be related to MDD/anxiety disorders, being
obese may further decrease mental QoL. In Western societies, where being thin is considered
attractive beauty, obesity might impact on an individual’s body image and self-esteem, and
thus be a source of clinically significant distress or depression, thereby reducing the quality of
life [39]. Hilbert et al have also shown that obese persons taking part in social activities face
more stigma and prejudice than do obese persons [40].
Furthermore, multivariate analyses showed that general and abdominal obesity were consis-
tently associated with a poorer physical QoL in persons both with and without MDD and/or
anxiety disorders. This finding is in line with a systematic review and several other studies [17,
41–50], which found a robust relationship between overweight, obesity and poorer HR-QoL.
The severity of obesity and treatment-seeking behavior might be underlying factors linking
obesity and poor physical QoL [17]. Higher body weight and an excess of visceral fat are associ-
ated with higher rates of health care utilization [17]. Persons who had sought treatment or
tried to lose weight were significantly more impaired on physical measures (e.g. bodily pain,
general health and vitality) of HR-QoL than those who did not try to lose weight [17]. As pre-
sented in this study, the physical measures of HR-QoL showed significant linear reductions in
obese persons, and the greatest decline (20 point lower) was observed in obese persons with
MDD and/or anxiety disorders (Table 2). The effect of obesity on mental QoL seems reduced
with increasing obesity in anxious individuals compared to depressed counterparts, but was
not statically significant after adjustment of potential confounders (Table 2 and Table 5).
Therefore, all forms of obesity are associated with poorer physical QoL, and the associations
may even be stronger in obese persons who also have MDD and/or anxiety disorders.
We did not find associations of general and abdominal obesity with mental QoL in persons
with MDD and/or anxiety disorders. The associations were explained by lifestyle factors and
chronic conditions. However, in persons without MDD and/or anxiety disorders, both general
and abdominal obesity were significantly associated with a better mental QoL after adjustment
for potential confounders. This finding contradicts those of Cameron et al [41] and Vetter et al
[44], who found that BMI change was associated with a decrease in mental QoL. Laaksonen
et al and Renzaho et al reported no association between obesity and mental QoL and other
mental health domains [43,45]. Possible explanations for these discrepancies are differences in
the assessment of MDD and anxiety disorders, the study population and confounding factors.
Most of the previous studies used self-reported measures of MDD and/or anxiety disorders
[37,43], while the present study used a psychiatric interview. In the previous studies, the poten-
tial interactions between obesity and MDD and/or anxiety disorders were also not considered.
Generally, mental health problems could be expected in obese persons because of the stigma
associated with excess body weight, but some obese persons appear to have essentially normal
psychosocial functioning. This might be due to several underlying factors, such as perceived
body image, self-esteem, and the level of severity and persistence of depressive disorders in
obese persons [39, 43]. It could also be due to the generic instrument used to assess mental
Qol, where the generic versions may not reflect the impact of weight related stigma and dis-
crimination issues on mental QoL in obese persons. Taken together, these results indicate that
the joint exposures of obesity and MDD and/or anxiety disorders are associated with poorer
physical and mental QoL; obesity alone has no effect on mental QoL in the general population.
Strengths and limitations
The major strength of our study is the nature of the study population, which is derived from
the general population and both large and well characterized. The sample size of N = 89,332
participants allowed us to perform subgroup analysis with different BMI categories and MDD
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and/or anxiety disorders status. Moreover, a comprehensive assessment of chronic conditions,
a psychiatric interview, and two anthropometry metrics, i.e. BMI andWC, were used. The sim-
ilar results for BMI and WC suggest that our results are robust.
The main limitation of our study is its cross-sectional nature, i.e. inferences concerning the
direction of the observed associations between obesity, MDD and/or anxiety disorders and
HR-QoL cannot be made. Moreover, the use of the RAND-36 may be a limitation, as many
researchers for its inadequate reflection of HR-QoL have criticized it. The RAND-36 may also
not cover all essential health aspects pertinent to a particular disease. However, it does have the
advantage of enabling HR-QoL comparisons across different diseases. It has been shown to
have had a high degree of responsiveness to diseases, by which it discriminates between people
in different categories of overweight and obesity, as presented here. Nevertheless, it is highly
important to sue a multidimensional instrument embracing different health aspects that do not
necessarily correlate to each other, such as obesity specific measures like the impact of weight
on quality of life (IWQoL-Lite). Furthermore, misclassification may have occurred in the mea-
surements of smoking and alcohol consumption, which were based on self-administered ques-
tionnaires. However, earlier studies have showed that self-reported smoking status and alcohol
consumption can be used with notable confidence and provide an estimate comparable to the
actual consumption [32, 49]. Finally, because data on the binge eating disorder (BED) was not
available we were not able to analyse the potential role of this variable in the association of obe-
sity and MDD and/or anxiety with poor HR-QoL. Further studies are needed to assess the
potential role of BED.
Practical and policy implications
In this large, representative study, we showed that in the general population the combination
of obesity and MDD and/or anxiety disorders is associated with a poor HR-QoL. This com-
bined effect may have implications for prevention and public health measures if confirmed in
prospective studies. The magnitude of the impact of obesity and MDD and/or anxiety disorders
on a range of HR-QoL dimensions indicates that the successful management of depression in
the primary care setting would result in a significant alleviation of suffering in obese adults. In
light of this, the weight-increasing side effects of many commonly used antidepressants should
also be considered. Where possible, a more restrained use of those antidepressants with the
greatest weight stimulating effects would seem advisable, in particular for obese persons [50].
Several studies have shown that a weight loss program can lead to a significant reduction in
depression scores [51]. Thus, monitoring depressive and anxiety symptoms is important in
obese persons, and maintaining normal weight or reducing excess weight would be by far the
best approach to improve the HR-QoL.
Conclusions
In conclusion, the combined effect of obesity and MDD and/or anxiety disorders on HR-QoL
is greater than the sum of the separate effects of obesity and MDD and/or anxiety disorders on
HR-QoL. Moreover, both general and abdominal obesity are associated with poor physical
QoL. General and abdominal obesity without MDD and/or anxiety disorders are associated
with better mental QoL. Longitudinal studies are needed to explore the causal pathways
between obesity, MDD and/or anxiety disorders and HR-QoL.
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